Labdane conjugates protect cardiomyocytes from doxorubicin‐induced cardiotoxicity
Sign Up to like & getrecommendations! Published in 2022 at "Drug Development Research"
DOI: 10.1002/ddr.22014
Abstract: The cardiovascular side effects associated with doxorubicin (DOX), a wide spectrum anticancer drug, have limited its clinical application. Therefore, to explore novel strategies with cardioprotective effects, a series of new labdane conjugates were prepared (6a–6c… read more here.
Keywords: labdane; induced cardiotoxicity; activity; labdane conjugates ... See more keywords